Abnormality of central somatosensory evoked potentials
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the cerebellum
|
0.100 |
CausalMutation
|
group |
CLINVAR |
|
|
|
Abnormality of the dentate nucleus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the face
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormality of the periventricular white matter
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of vision
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adult Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CYP27A1 protein was upregulated in glioblastoma tissues, indicating that CYP27A1 is an oncogene.
|
30008822 |
2018 |
Age related macular degeneration
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Previously, the CYP27A1 Lys(358)-isoLG adduct was found in human retina afflicted with age-related macular degeneration.
|
23479405 |
2013 |
Age related macular degeneration
|
0.020 |
Biomarker
|
disease |
BEFREE |
We suggest a mechanism whereby abolished sterol 27-hydroxylase activity leads to vascular changes and identify Cyp27a1-/- mice as a model for one of the variants of type 3 retinal neovascularization occurring in some patients with age-related macular degeneration.
|
22820291 |
2012 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In Alzheimer's disease (AD), CYP46A1 shows prominent expression in astrocytes and around amyloid plaques, whereas CYP27A1 expression decreases in neurons and is not apparent around amyloid plaques but increases in oligodendrocytes.
|
15148325 |
2004 |
Amyotrophic Lateral Sclerosis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CYP27A1 are causal to cerebrotendinous xanthomatosis which can present as a clinical mimic of ALS with progressive upper motor neuron loss, making it a plausible susceptibility gene for ALS.
|
22509407 |
2012 |
Amyotrophic Lateral Sclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
In view of the fact that CTX can present with upper motor neuronal signs it is interesting that CYP27 has been shown to be a candidate gene for sporadic ALS.
|
23759795 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
The gene encoding cholesterol 27-hydroxylase, CYP27A1, was recently identified as a susceptibility gene for sporadic ALS.
|
25415378 |
2014 |
Amyotrophic Lateral Sclerosis, Sporadic
|
0.010 |
Biomarker
|
disease |
BEFREE |
CYP27A1 was identified as a candidate gene for sporadic amyotrophic lateral sclerosis (ALS).
|
23759795 |
2013 |
Anastomosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further, Cyp27a1-null mice showed pathological neovascularization, which likely arose from both the retina and the choroid, that led to the formation of retinal-choroidal anastomosis.
|
22820291 |
2012 |
Angina Pectoris
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Arteriosclerosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
CYP27A1 is the known causative gene of cerebrotendinous xanthomatosis, a disorder which is sometimes accompanied by early onset atherosclerosis.
|
24080357 |
2013 |
Arteriosclerosis
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Genetic heterogeneity resulting in differences in sterol 27-hydroxylase activity between individuals may affect their ability to deal with accumulated cholesterol in the arterial intima, and hence their relative degree of predisposition to atherosclerosis.
|
11166758 |
2001 |
Arteriosclerosis
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
A further impetus for exploring the normal biologic roles that are served by expression of the CYP27A1 gene is the knowledge that mutations in humans are associated with accelerated atherosclerosis and with severe neurologic impairment.
|
11111083 |
2000 |
Arteriosclerosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
Patients with inherited "cerebrotendinous xanthomatosis" lack sterol 27-hydroxylase (CYP27A1) and develop severe premature atherosclerosis despite normal serum cholesterol concentrations.
|
19801147 |
2010 |
Arthritis, Psoriatic
|
0.010 |
Biomarker
|
disease |
BEFREE |
Additionally, 1,25(OH)2D significantly increased ATP levels and gene expression related to mitochondrial function such as carnitine palmitoyltransferase 1 (CPT1), peroxisome proliferator-activated receptor α (PPARα), very long-chain acyl-CoA dehydrogenase (VLCAD), long-chain acyl-CoA dehydrogenase (LCAD), medium-chain acyl-CoA dehydrogenase (MCAD), uncoupling protein 2 (UCP2), and UCP3 and the vitamin D pathway including 25-dihydroxyvitamin D3 24-hydroxylase (CYP24) and 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27) in PA-treated C2C12 myotubes.
|
31744213 |
2019 |
Asthma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Asthma was also associated with TT haplotype of CYP27A1 and AGGATA haplotype of CYP2R1 (p = 0.021 and 0.024, respectively).
|
25845986 |
2015 |
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Atherogenesis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A potential role for sterol 27-hydroxylase in atherogenesis.
|
11166758 |
2001 |
Atherogenesis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol.
|
19801147 |
2010 |